Table 4.
Gains and Losses Detected by SNP Array and qPCR
| Patient ID | Gains on Chromosome 5 | Losses on Chromosome 6 | ||||
| Detected by | Detected by | |||||
| SNP Array | qPCR CSF1R | SNP Array* | qPCR PACRG | qPCR PARK2 | ||
| 4 | ■ | NA | □ | NA | NA | |
| 7 | ■ | NA | □ | NA | NA | |
| 26 | ■ | □ | □ | ■ | ■ | |
| 28 | □ | ■ | □ | ■ | □ | |
| 31 | □ | □ | ■ | ■ | ■ | |
| 44 | □ | ■ | □ | ■ | □ | |
| 65 | ■ | NA | □ | NA | NA | |
| 69 | ■ | ■ | □ | ■ | ■ | |
| 81 | ■ | NA | □ | NA | NA | |
| 88 | □ | □ | □ | ■ | NE | |
| 122 | □ | □ | ■ | ■ | ■ | |
| 126 | □ | ■ | □ | ■ | ■ | |
| 132 | □ | ■ | □ | ■ | ■ | |
| 135 | ■ | □ | □ | ■ | □ | |
| 139 | ■ | ■ | □ | ■ | ■ | |
| 154 | □ | ■ | ■ | NE | NE | |
| 163 | □ | ■ | ■ | ■ | □ | |
| 167 | □ | ■ | ■ | ■ | □ | |
| 178 | □ | NA | □ | NA | NA | |
| 182 | ■ | NA | ■ | NA | NA | |
| 195 | ■ | ■ | □ | ■ | □ | |
| 201 | □ | ■ | ■ | ■ | ■ | |
■ indicates detectable aberration (gain or loss); □, no detectable aberration (gain or loss); NA, cDNA not available; NE, not evaluable because the target gene in both tumor and nonmalignant tissues was under the detection limit.
Includes large aberrations and microdeletions.